Our Focus
THE INDUSTRY HAS CHALLENGE AND OPPORTUNITY:
- Reimbursement policies demand cost effectiveness for new products in the U.S., still the largest market.
- Regulatory indecisiveness makes complex clinical development daunting.
BUT
- New demand for better healthcare exists around the world – often for solutions which are simpler and more cost effective. New technology addresses these concerns while allowing for far greater access to care.
OUR FOCUS ACROSS HEALTHCARE INVESTING HAS EVOLVED. It isn't just disease incidence and prevalence anymore. It's systemic efficiencies and global opportunities. And not just drugs and devices, but an array of new technologies to provide better and efficient care. The result: information management and communications, diagnostics, and therapeutic discovery and delivery are changing dramatically, and for the better.
 |
"Many firms talk about healthcare technology convergence. Aberdare is actually DOING convergence, committing real resources and dollars. Smart, passionate… want the real deal? Get these folks on board and you're getting more than capital." - Jae Chung, Founder & CEO, goBalto, Inc. |  |
|
"Aberdare digs into the company's space in the world and the issues it faces as it tries to become a presence in that space and they are exceptionally thoughtful about setting company direction and dealing with issues along the way." - Pat Mahaffy, President & CEO, Clovis Oncology | |
|
"I've met few investors who truly understand the landscape in the intersection of healthcare and technology. The Aberdare team is knowledgeable and diverse in both domains, and have become the leader in digital health investing." - Halle Tecco, Founder & Managing Director, Rock Health | |
|
"Aberdare has a fresh optimism about what they are doing. They are out looking for things that CAN be done." - James Currier, Founder & Chairman, Jiff |
|